‘Not Much We Can Do’: Vaccine Makers Lash Out at RFK Jr. as Sales Slide

Vaccine industry executives are publicly blaming U.S. Health Secretary Robert F. Kennedy Jr. for tanking stock prices, declining vaccine sales in the U.S. and their reluctance to invest in clinical trials for new vaccines.

Asked what would need to change to move vaccine discussions forward, Pfizer CEO Albert Bourla answered: “The secretary of health,” The Wall Street Journal reported Wednesday.

Bourla has emerged as Kennedy’s most vocal critic, calling his approach “anti-science.”

. . .